Switzerland· 57629002
Zonegran 25 mg, Kapseln
A zonisamide product containing zonisamidum, registered in Switzerland by Curatis AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Zonisamide is registered in 18 of 19 countries.
Countries holding a registration under ATC N03AX15 (zonisamide), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 11 of them publish a price we can compare per daily dose
Zonisamide · ATC N03AX15
18 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of zonisamide costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.78 in United States to $10.28 in Switzerland — a ×13 gap.
- Switzerland: $10.28 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Zonisamide · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$10.28
- IT Italy$2.90
- FR France$1.20
- US United States$0.78 (acquisition cost)
The record
At a glance
Swissmedic (Switzerland)- Active substance
- zonisamidum
- Manufacturer
- Curatis AG
- Country
- Switzerland (CH)
- ATC code
- N03AX15
- ATC class
- Zonisamide
- Defined daily dose
- 0.4 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768057629002414 StkCHF 27.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
239 interactions on record for zonisamide.
Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zonisamide · interactions on record
239 records
- 43 severe
- 105 moderate
- 66 info
Most severe, free to view
- DicycloverineA03AA07severe
- PropanthelineA03AB05severe
- MepenzolateA03AB12severe
- TrospiumA03AB20severe
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Zonisamide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomZonegran 25mg capsulesDE Pharmaceuticals
- SpainNYZOL 25 MG CAPSULAS DURAS EFGNeuraxpharm Spain S.L.
- United StatesZonegranAdvanz Pharma (US) Corp.
- CzechiaERSITTINEgis Pharmaceuticals PLC, Budapešť
- FinlandZonegranParanova Oy
- FranceZONEGRAN 25 mg, géluleAMDIPHARM
- NetherlandsZonegran 25 mg, capsules hardAmdipharm Limited
- IrelandZonegran 25 mg hard capsulesAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Zonisamid Aristo
- Bulgaria · Зокап
- Czechia · Ersittin, Zonisamid Sandoz
- Germany · Zonisamid 1 A Pharma, Zonisamid Accord
- Denmark · Zonisamid Desitin, Zonisamid Glenmark
- Estonia · Zonisamide Sandoz
- Spain · Nyzol, Zonesme
- Finland · Zonisamide Desitin
- France · Zonisamide Arrow, Zonisamide Neuraxpharm
- United Kingdom (Northern Ireland) · Desizon, Zonisamide Accord
- Croatia · Zocap
- Ireland · Zonisamide Desitin, Zonisamide Rowex
- Iceland · Zonegran, Zonisamide Viatris
- Italy · Zonisamide Doc Generici, Zonisamide Sandoz
- Liechtenstein · Zonegran, Zonisamide Viatris
- Lithuania · Zonisamide Sandoz
- Malta · Zonisamide Doc Generici
- Netherlands · Zonisamide Indoco, Zonisamide Sandoz
- Norway · Zonegran, Zonisamid Desitin
- Poland · Zonisamidum Neuraxpharm
- Portugal · Zonisamida Aristo, Zonisamida Generis
- Romania · Zocap, Zonisamidă Desitin
- Sweden · Zonisamide 1a Farma
- Slovenia · Zocap, Zonisamid Sandoz
- Slovakia · Zonisamide Neuraxpharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0a638a65-324d-46c4-abe8-8a36b214e48b GET /v1/drugs/0a638a65-324d-46c4-abe8-8a36b214e48b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "zonisamidum 25 mg",
"valid_from": "2007-03-01",
"limitations": "[{\"description\":\"Patienten, die gegenüber der Standardtherapie refraktär sind.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2007-01-01\"},{\"description\":\"Monotherapie für die Behandlung von fokalen Anfällen mit oder ohne sekundäre Generalisierung bei Erwachsenen mit neu diagnostizierter Epilepsie.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2013-12-01\"}]",
"galenic_form": "Kaps 25 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2007-03-01",
"self_retention_pct": 10
}See everything about zonisamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.